Publications by authors named "Michael Gent"

Claim this Profile
A
A warning from the past that is best ignored? Transfusing ABO-specific red blood cells after incompatible plasma transfusion in trauma.
Mark H Yazer, Philip C Spinella, Emily Mayhew, John R Hess, Jennifer Gurney, J Michael Van Gent

Transfusion· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new look at an old warning: Transfusing ABO group-specific red blood cells after large-volume low-titer group O whole blood in trauma resuscitation.
Mark H Yazer, Philip C Spinella, Emily Mayhew, John R Hess, Jennifer Gurney, J Michael Van Gent

Transfusion· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing Opiates Off the Streets and Undertaking Excess Scripts: A novel opiate reclamation and prescription reduction program.
Paul R Lewis, Casey Pelzl, Emily Benzer, Sean Szad, Carolyn Judge, Michael Van Gent

Surgery· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Transfused Citrate on Pathophysiology in Massive Transfusion.
Jacob B Schriner, J Michael Van Gent, M Adam Meledeo, Scott D Olson, Bryan A Cotton

Crit Care Explor· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rare case of survival after traumatic blunt ventricular rupture.
Ryan Yang, Michael Van Gent, Thomas Clements, Bryan Cotton, Michael Wandling

J Surg Case Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
Theodore E Warkentin, Bruce L Davidson, Harry R Büller, Alexander Gallus, Michael Gent

Chest· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malformations of cortical development.
Sangam Kanekar, Michael Gent

Semin Ultrasound CT MR· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
Alexander G G Turpie, Michael Rud Lassen, Bengt I Eriksson, Michael Gent, Scott D Berkowitz

Thromb Haemost· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).
Paul Dorian, Stefan H Hohnloser, Kevin E Thorpe, Robin S Roberts, Karl-Heinz Kuck, Michael Gent

Circulation· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
Frederiek F van Doormaal, Alexander T Cohen, Bruce L Davidson, Herve Decousus, Alexander S Gallus, Michael Gent

Thromb Haemost· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Alexander G G Turpie, Michael R Lassen, Bruce L Davidson, Kenneth A Bauer, Michael Gent

Lancet· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
Carl A Laskin, Karen A Spitzer, Christine A Clark, Mark R Crowther, Jeff S Ginsberg, Michael Gent

J Rheumatol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, William D Fisher, Michael Gent

Thromb Haemost· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial.
Clive Kearon, Jim A Julian, Michael J Kovacs, David R Anderson, Philip Wells, Michael Gent

Blood· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
Wolfgang Mueck, Bengt I Eriksson, Kenneth A Bauer, Lars Borris, Ola E Dahl, Michael Gent

Clin Pharmacokinet· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial.
John A Cairns, Janet Wittes, D George Wyse, Janet Pogue, Michael Gent

Am Heart J· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idraparinux versus standard therapy for venous thromboembolic disease.

N Engl J Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended prophylaxis of venous thromboembolism with idraparinux.

N Engl J Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
William D Fisher, Bengt I Eriksson, Kenneth A Bauer, Lars Borris, Ola E Dahl, Michael Gent

Thromb Haemost· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study.
Michael D Hill, David M Kent, Judith Hinchey, Howard Rowley, Alastair M Buchan, Michael Gent

Stroke· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
Clive Kearon, Jeffrey S Ginsberg, Jim A Julian, James Douketis, Susan Solymoss, Michael Gent

JAMA· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.
Stefan H Hohnloser, Paul Dorian, Robin Roberts, Michael Gent, Carsten W Israel

Circulation· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial.
Clive Kearon, Jeffrey S Ginsberg, James Douketis, Alexander G Turpie, Shannon M Bates, Michael Gent

Ann Intern Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Stuart J Connolly, Paul Dorian, Robin S Roberts, Michael Gent, Steven Bailin

JAMA· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant association with location of central venous line placement and risk of venous thrombosis in children.
Christoph Male, Jim A Julian, Patricia Massicotte, Michael Gent, Lesley Mitchell

Thromb Haemost· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis